BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lovisa S, Genovese G, Danese S. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. J Crohns Colitis. 2019;13:659-668. [PMID: 30520951 DOI: 10.1093/ecco-jcc/jjy201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 2021;302:211-27. [PMID: 33993489 DOI: 10.1111/imr.12974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luo Y, Liu S, Li H, Hou J, Lin W, Xu Z, Lu T, Li Y, Peng B, Zhang S, Han X, Kuang Z, Wen Y, Cai J, Liu F, Chen X. Mass Cytometry and Single-Cell Transcriptome Analyses Reveal the Immune Cell Characteristics of Ulcerative Colitis. Front Mol Biosci 2022;9:859645. [DOI: 10.3389/fmolb.2022.859645] [Reference Citation Analysis]
3 Li T, Liu W, Hui W, Shi T, Liu H, Feng Y, Gao F, Mi Y. Integrated Analysis of Ulcerative Colitis Revealed an Association between PHLPP2 and Immune Infiltration. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/4983471] [Reference Citation Analysis]
4 Li C, Kuemmerle JF. The fate of myofibroblasts during the development of fibrosis in Crohn's disease. J Dig Dis 2020;21:326-31. [PMID: 32092217 DOI: 10.1111/1751-2980.12852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Ghorbaninejad M, Meyfour A, Maleknia S, Shahrokh S, Abdollahpour-alitappeh M, Asadzadeh-aghdaei H. Inhibition of epithelial SHH signaling exerts a dual protective effect against inflammation and epithelial–mesenchymal transition in inflammatory bowel disease. Toxicology in Vitro 2022. [DOI: 10.1016/j.tiv.2022.105382] [Reference Citation Analysis]
6 Rosendorf J, Klicova M, Herrmann I, Anthis A, Cervenkova L, Palek R, Treska V, Liska V. Intestinal Anastomotic Healing: What do We Know About Processes Behind Anastomotic Complications. Front Surg 2022;9:904810. [DOI: 10.3389/fsurg.2022.904810] [Reference Citation Analysis]
7 Kim TW, Shin JS, Chung KS, Lee YG, Baek NI, Lee KT. Anti-Inflammatory Mechanisms of Koreanaside A, a Lignan Isolated from the Flower of Forsythia koreana, against LPS-Induced Macrophage Activation and DSS-Induced Colitis Mice: The Crucial Role of AP-1, NF-κB, and JAK/STAT Signaling. Cells 2019;8:E1163. [PMID: 31569788 DOI: 10.3390/cells8101163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
8 Krzystek-Korpacka M, Fleszar MG, Bednarz-Misa I, Lewandowski Ł, Szczuka I, Kempiński R, Neubauer K. Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings. Int J Mol Sci 2020;21:E1641. [PMID: 32121248 DOI: 10.3390/ijms21051641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Jing H, Wang S, Wang Y, Shen N, Gao X. Environmental contaminant ammonia triggers epithelial-to-mesenchymal transition-mediated jejunal fibrosis with the disassembly of epithelial cell-cell contacts in chicken. Science of The Total Environment 2020;726:138686. [DOI: 10.1016/j.scitotenv.2020.138686] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
10 Mamie C, Bruckner RS, Lang S, Shpigel NY, Turina M, Rickenbacher A, Cabalzar-Wondberg D, Chvatchko Y, Rogler G, Scharl M. MMP9 expression in intestinal fistula from patients with fistulizing CD and from human xenograft mouse model. Tissue Barriers 2021;:1994350. [PMID: 34709129 DOI: 10.1080/21688370.2021.1994350] [Reference Citation Analysis]
11 Hao W, Li M, Cai Q, Wu S, Li X, He Q, Hu Y. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Front Physiol 2022;13:889792. [DOI: 10.3389/fphys.2022.889792] [Reference Citation Analysis]
12 Pasztoi M, Ohnmacht C. Tissue Niches Formed by Intestinal Mesenchymal Stromal Cells in Mucosal Homeostasis and Immunity. IJMS 2022;23:5181. [DOI: 10.3390/ijms23095181] [Reference Citation Analysis]
13 Lis-López L, Bauset C, Seco-Cervera M, Cosín-Roger J. Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomedicines 2021;9:1747. [PMID: 34944564 DOI: 10.3390/biomedicines9121747] [Reference Citation Analysis]
14 Lu Y, Guan T, Xu S, Chen YE, Shen Q, Zhu S, Liu Y, Liang J, Hou S. Asperuloside inhibited epithelial-mesenchymal transition in colitis associated cancer via activation of vitamin D receptor. Phytomedicine 2022;101:154070. [PMID: 35523114 DOI: 10.1016/j.phymed.2022.154070] [Reference Citation Analysis]
15 Rosendorf J, Klicova M, Cervenkova L, Palek R, Horakova J, Klapstova A, Hosek P, Moulisova V, Bednar L, Tegl V, Brzon O, Tonar Z, Treska V, Lukas D, Liska V. Double-layered Nanofibrous Patch for Prevention of Anastomotic Leakage and Peritoneal Adhesions, Experimental Study. In Vivo 2021;35:731-41. [PMID: 33622866 DOI: 10.21873/invivo.12314] [Reference Citation Analysis]
16 Zhou LY, Lin SN, Rieder F, Chen MH, Zhang SH, Mao R. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside. Inflamm Bowel Dis 2021;27:971-82. [PMID: 33324986 DOI: 10.1093/ibd/izaa321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E, Martinotti S, Conti P, Flati V. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders. Front Cell Dev Biol 2020;8:607483. [PMID: 33409282 DOI: 10.3389/fcell.2020.607483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Boros É, Prontvai B, Kellermayer Z, Balogh P, Sarlós P, Vincze Á, Varga C, Maróti Z, Bálint B, Nagy I. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules 2020;10:E974. [PMID: 32610492 DOI: 10.3390/biom10070974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Unterweger AL, Rüscher A, Seuß M, Winkelmann P, Beigel F, Koletzko L, Breiteneicher S, Siebeck M, Gropp R, Aszodi A. NOD/scid IL-2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype. Immun Inflamm Dis 2021. [PMID: 34499803 DOI: 10.1002/iid3.516] [Reference Citation Analysis]
20 Strowitzki MJ, Ritter AS, Kimmer G, Schneider M. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease? Pharmacol Res 2019;147:104364. [PMID: 31376431 DOI: 10.1016/j.phrs.2019.104364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Bislenghi G, Wolthuis A, Van Assche G, Vermeire S, Ferrante M, D'Hoore A. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease. Expert Opin Biol Ther. 2019;19:607-616. [PMID: 31121104 DOI: 10.1080/14712598.2019.1623876] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
22 Motofei IG. Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Semin Cancer Biol 2021:S1044-579X(21)00253-4. [PMID: 34695580 DOI: 10.1016/j.semcancer.2021.10.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chen B, Dong W, Shao T, Miao X, Guo Y, Liu X, Feng Y. A KDM4-DBC1-SIRT1 Axis Contributes to TGF-b Induced Mesenchymal Transition of Intestinal Epithelial Cells. Front Cell Dev Biol 2021;9:697614. [PMID: 34631698 DOI: 10.3389/fcell.2021.697614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 D'Alessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34876680 DOI: 10.1038/s41575-021-00543-0] [Reference Citation Analysis]
25 Boros É, Nagy I. The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Cells 2019;8:E1461. [PMID: 31752264 DOI: 10.3390/cells8111461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Yin J, Ye YL, Hu T, Xu LJ, Zhang LP, Ji RN, Li P, Chen Q, Zhu JY, Pang Z. Hsa_circRNA_102610 upregulation in Crohn’s disease promotes transforming growth factor-β1-induced epithelial-mesenchymal transition via sponging of hsa-miR-130a-3p. World J Gastroenterol 2020; 26(22): 3034-3055 [PMID: 32587447 DOI: 10.3748/wjg.v26.i22.3034] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Li W, Yu J, Jin B, Zhang H, Zhang J. Protective Effects of Aminooxyacetic Acid on Colitis Induced in Mice with Dextran Sulfate Sodium. Biomed Res Int 2021;2021:1477345. [PMID: 35299827 DOI: 10.1155/2021/1477345] [Reference Citation Analysis]
28 Vieujean S, Hu S, Bequet E, Salee C, Massot C, Bletard N, Pierre N, Quesada Calvo F, Baiwir D, Mazzucchelli G, De Pauw E, Coimbra Marques C, Delvenne P, Rieder F, Louis E, Meuwis MA. Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homolog in Crohn's Disease Fibrosis. J Crohns Colitis 2021:jjab061. [PMID: 33822017 DOI: 10.1093/ecco-jcc/jjab061] [Reference Citation Analysis]
29 Meng ZW, Baumgart DC. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease. Expert Rev Gastroenterol Hepatol 2020;14:405-10. [PMID: 32354239 DOI: 10.1080/17474124.2020.1764349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]